Lung cancer is now the number one cause of cancer death for both men and wo
men. An age-adjusted analysis over the past 25 gears shows that in women sp
ecifically, lung cancer incidence is on the rise. It is estimated that 10-2
0 genetic events including the alteration of oncogenes and tumor suppressor
genes will have occurred by the time a lung tumor becomes clinically evide
nt. In an effort to identify regions containing novel cancer genes, chromos
ome 18p11, a band not previously implicated in disease, was examined for lo
ss of heterozygosity (LOH). In this study, 50 matched normal and NSCLC tumo
r samples were examined using sis 18p11 and one 18q12.3 PCR-based polymorph
ic markers. In addition, LOH was examined in 29 glioblastoma pairs and 14 p
aired breast carcinomas. This analysis has revealed potentially two regions
of LOH in 18p11 in up to 38% of the tumor samples examined, The regions of
LOH identified included a 2 cm area between markers D18S59 and D18S476, an
d a more proximal, 25 cm region of intermediate frequency between D18S452 a
nd D18S453, These results provide evidence for the presence of one or more
potential tumor suppressor genes on the short arm of chromosome 18 which ma
y be involved in NSCLC, brain tumors and possibly breast carcinomas as well
.